Zobrazeno 1 - 2
of 2
pro vyhledávání: '"van Tinteren, Harm"'
Autor:
Straver ME; Department of Surgical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. m.straver@nki.nl, Glas AM, Hannemann J, Wesseling J, van de Vijver MJ, Rutgers EJ, Vrancken Peeters MJ, van Tinteren H, Van't Veer LJ, Rodenhuis S
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2010 Feb; Vol. 119 (3), pp. 551-8. Date of Electronic Publication: 2009 Feb 13.
Autor:
Bueno-de-Mesquita JM; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., van Harten WH; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands., Retel VP; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands., van 't Veer LJ; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Agendia, Amsterdam, Netherlands., van Dam FS; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands., Karsenberg K; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands., Douma KF; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands., van Tinteren H; Biometric Department, Netherlands Cancer Institute, Amsterdam, Netherlands., Peterse JL; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Wesseling J; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Wu TS; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Atsma D; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Rutgers EJ; Division of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Brink G; Agendia, Amsterdam, Netherlands., Floore AN; Agendia, Amsterdam, Netherlands., Glas AM; Agendia, Amsterdam, Netherlands., Roumen RM; Department of Surgery, Maxima Medical Centre, Eindhoven, Netherlands., Bellot FE; Department of Pathology, Spaarne Hospital, Hoofddorp, Netherlands., van Krimpen C; Department of Pathology, Reinier de Graaf Hospital, Delft, Netherlands., Rodenhuis S; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., van de Vijver MJ; Department of Pathology, Divisions of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, Academic Medical Centre, Amsterdam, Netherlands., Linn SC; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. Electronic address: s.linn@nki.nl.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2007 Dec; Vol. 8 (12), pp. 1079-1087. Date of Electronic Publication: 2007 Nov 26.